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Abstract
The molecular events associated with the transcriptive and replicative cycle of negative-stranded RNA viruses are still an enigma. We
took Chandipura virus, a member of the Rhabdoviridae family, as our model system to demonstrate that Phosphoprotein P, besides
Nucleocapsid protein N, also acts as a leader RNA-binding protein in its unphosphorylated form, whereas CKII-mediated phosphorylation
totally abrogates its RNA-binding ability. However, interaction between P protein and leader RNA can be distinguished from N-mediated
encapsidation of viral sequences. Furthermore, P protein bound to leader chain can successively recruit N protein on RNA while itself being
replaced. We also observed that the accumulation of phosphorylation null mutant of P protein in cells results in enhanced genome RNA
replication with concurrent increase in the viral yield. All these results led us to propose a model explaining viral transcription-replication
switch where Phosphoprotein P acts as a modulator of genome transcription and replication by its ability to bind to the nascent leader RNA
in its unphosphorylated form, promoting read-through of the transcription termination signals and initiating nucleocapsid assembly on the
nascent RNA chain.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
All members of the recently classified virus order
Mononegavirales contain a nonsegmented, negative-
stranded, 11- to 19-kb-long RNA genome that is tightly
wrapped in a nucleocapsid structure (Bishop, 1971). Vesic-
ular stomatitis virus (VSV), the prototype Rhabdovirus,
remains one of the best-studied models because of the
availability of in vitro (Barik and Banerjee, 1992; Patton et
al., 1984; Peluso and Moyer, 1988) and in vivo (Lawson et
al., 1995; Pattnaik et al., 1992; Whelan et al., 1995) systems
for assaying transcription and replication. VSV genome
RNA codes for five viral genes (N, P, M, G, L) and a short
leader RNA (I) complementary to the 3 end of the genome
(Banerjee, 1987). The nucleocapsid protein N protects the
genome from degradation. The large protein L (240 kDa),
and the major phosphoprotein P (29 kDa) constitute the
viral RNA polymerase, where L is the catalytic subunit and
P is the cofactor (Banerjee and Barik, 1992). Contransfec-
tion of the plasmids encoding these three proteins (N, L, and
P) along with cDNAs to the viral genomes or minigenomes
in host cells demonstrated that these three viral proteins are
necessary and sufficient for transcription and replication of
the virus (Pattnaik et al., 1992, 1997).
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The VSV life cycle has two major steps. In the first step,
the viral RNA polymerase transcribes the viral genome. The
viral polymerase, packaged within the virion particle, ini-
tiates transcription at the 3 end of the RNA genome, re-
sulting in the synthesis of a short (50 bases) leader RNA
and separate monocistronic mRNAs with progressive atten-
uation of transcription at each intergenic junction (Abraham
and Banerjee, 1976; Iverson and Rose, 1981). The transcrip-
tion of the viral genome does not require synthesis of new
protein, although it largely depends on the phosphorylated
form of P protein (Banerjee, 1987). The second step is the
replication of the viral genome, which needs synthesis of
viral proteins (Wertz and Levine, 1973). In the replication
mode, the RNA polymerase transcribes the same template to
produce a polycistronic, positive-strand RNA complemen-
tary to the whole genome, which serves as template for
subsequent synthesis of progeny genome RNAs (Banerjee,
1987; Wertz and Levine, 1973). Despite detailed analysis of
these two steps, the molecular event that leads to the tran-
sition from transcription to the replication mode is largely
unknown.
One of the molecules that has been implicated in the
transcription–replication switch is the viral N protein. The
intracellular concentration of N protein modulates the tran-
sition of the polymerase action from transcription to repli-
cation by encapsidating the nascent leader RNA and thereby
suppressing the intergenic transcription termination signals
(Blumberg et al., 1981; Wertz et al., 1998). However, N
protein tends to form inactive aggregates in the absence of
P protein and associates nonspecifically with cellular RNA
(Blumberg et al., 1983; Sprague et al., 1983). The inactive
aggregated form of N can bind to viral leader RNA but is
unable to encapsidate the genome RNA (Blumberg et al.,
1983). The accumulation of a critical amount of the repli-
cation-competent form of N protein is believed to be con-
trolled by the phosphoprotein P. The phosphoprotein P
through its C-terminus interacts (Takacs et al., 1993). and
keeps the N protein in a soluble and active form (Gupta and
Banerjee, 1997; Howard and Wertz, 1989). N–P protein
complexes have been observed in VSV-infected cells (La
Ferla and Peluso, 1989; Masters and Banerjee, 1988; Rich-
ardson and Peluso, 1996) and it was proposed that the
formation of this complex might be one of the ways to
regulate two events of RNA synthesis (Abraham and Ban-
erjee, 1976). Infected cell extract immunodepleted of N–P
complex with an antibody against P protein was unable to
support replication in an in vitro assay (Richardson and
Peluso, 1996). In the absence of P protein, N interacts with
nonspecifically with the phosphate backbone of RNA. How-
ever, in the presence of P protein N interacts with a specific
sequence of the leader RNA (Keene et al., 1981; Masters
and Banerjee, 1988). All these reports strongly suggest a
possible auxiliary function of P protein in viral replication.
In this article we have investigated the role of P protein
in transcription–replication switch using Chandipura virus
(CHP) as a model system. This rhabdovirus was isolated in
India and closely resembles VSV (Bhatt and Rodrigues,
1967; Gadkari and Pringle, 1980; Masters and Banerjee,
1987). Sequence at the 3 end of the CHP genome shows
remarkable homology up to first 18 bases with that of both
serotypes of VSV (Giorgi et al., 1983). Previously we have
shown that phosphorylation by Casein Kinase II (CKII) at
single serine residue (ser62) in the N-terminus of P protein
is required for its activity in transcription reconstitution
assay (Chattopadhyay et al., 1997). Here we used in vitro
synthesized CHP leader RNA to study its interaction with
unphosphorylated (P0) or CKII-phosphorylated (P1) forms
of P protein and also its interaction with N protein (Majum-
der et al., 2001). The relevance of the results obtained from
the in vitro RNA-binding assays was tested in vivo by
allowing the CHP virus to multiply within Vero cells, har-
boring a performed pool of wild-type or phosphorylation-
negative mutant of P protein. As a further support we have
also performed virion-mediated in vitro transcription assays
under the same conditions. This article presents a demon-
stration of a probable regulatory role of P protein phosphor-
ylation in modulating a transcription–replication transition.
Results
Unphosphorylated P protein binds to the leader RNA
in vitro
The treatment of VSV-infected cell extract with phos-
phatase or its inhibitor results in an increase or inhibition of
full-length RNA synthesis and subsequent secondary tran-
scription, respectively (Chuang et al., 1997; Richardson and
Peluso, 1996). Work on rabies virus major phosphoprotein
N suggested that the phosphoprotein regulates virus tran-
scription and replication via its ability to interact with the
leader RNA (Yang et al., 1999). We questioned whether the
CHP major phosphoprotein P interacts with the cognate
leader RNA. To this end we cloned the CHP leader gene and
trailer region and performed gel retardation assay to score
the interaction between recombinant unphosphorylated P
protein (P0) and leader RNA (I). Fig. 1A shows the binding
ability of P0 toward leader RNA in a background of 100-
fold molar excess of yeast tRNA (lane 5) where nearly the
entire input leader RNA formed a slower migrating com-
plex, whereas neither BSA nor bacterial extract lacking P
protein interacted with the leader sequence (lanes 3 and 4)
in the same assay condition. The complex formation was
completely prevented in the presence of 100-fold molar
excess of cold leader RNA showing specificity of interac-
tion (lane 6). We have also excluded the possibility of
involvement of 12-nt vector-derived sequence present in the
leader transcript in the complex formation by incubating
labeled nonviral control RNA having the same sequence in
its 5 terminal with or without P0 (lanes 7 and 8). We have
also carried out an antibody supershift experiment using
antibody against P protein that confirms the shifted complex
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Fig. 1. Phosphoprotein P in its unphosphorylated form interacts reversibly with leader RNA. (A) The RNA binding ability of P protein in its unphosphorylated
form was tested by gel retardation assay (GRA). Three nanograms of labeled leader RNA (I*) (60,000 cpm) was incubated in binding-phosphorylation buffer
containing 100-fold molar excess of yeast tRNA either alone (lane 2) or in the presence of 3 g of BSA (lane 3) or 5 g of BL21 DE3 cell extract (lane
4) or 3 g of bacterially expressed P protein (P0) (lanes 5 and 6) at 37°C for 15 min. Lane 6 contains 100-fold molar excess of cold leader RNA as competitor.
A pGEM-4Z vector-derived nonviral RNA used as a control (lanes 7 and 8) in the RNA binding assay. In antibody supershift experiments anti-P antibody
was added to the reaction mixture at the completion of I*P0 complex formation with further incubation for 15 min (lane 9). Complexes were resolved onto
6% native gel. BB and XC correspond to Bromphenol blue and xylene cyanol. (B) Reversibility and specificity of RNA binding activity of P protein was
tested by GRA. P0 (350 ng) was incubated with 3 ng of I* for 15 min as described earlier to allow the complex to form. The preformed complex was then
challenged with buffer (lanes 2, 8, and 14) or with equal (lanes 3, 9, and 15), twofold (lanes 4, 10, and 16), fivefold (lanes 5, 11, and 17) or 10-fold (lanes
6, 12, and 18) molar excess of cold leader RNA, nonviral RNA or trailer RNA, respectively. The reaction mixtures were further incubated for 15 min before
resolving on native gel.
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to be P specific (lane 9). This evidence led us to conclude
that unphosphorylated P protein specifically interacts with
the viral leader RNA in vitro.
Next we asked whether the P0–leader RNA interaction is
reversible in nature. To address that, preformed P0–I com-
plex was challenged with an increasing amount of cold
leader RNA and the entire reaction mixture was incubated
for another 15 min (Fig. 1B, lanes 3–6). The cold RNA
competed out P0-bound labeled leader RNA and fivefold
molar excess of cold RNA resulted in total displacement
(Fig. 1B, lane 5), whereas a pGEM-4Z vector-derived non-
viral RNA of similar size had no effect (Fig. 1B, lanes
9–12). Our reversibility data suggest this interaction to be
temporal in nature in an in vivo situation. By immunopre-
cipitating N–P complex from VSV-infected cell extract,
Peluso and Moyer (1988) showed that though this complex
is essential for the viral replication, only the N protein of
this complex remains associated with the replication prod-
uct. The reversible nature of P0–leader RNA complex is
consistent with this observation. Negative-stranded progeny
genome RNAs are synthesized from the positive-stranded
full-length template during replication. In this step RNA
synthesis initiates from the complementary trailer sequence
that has a very close homology (70%) with the leader RNA
(Leppert et al., 1979; Nichol and Holland, 1987). So we
tested the ability of trailer sequence to reverse P0–leader
RNA interaction. Our result showed that it can compete the
leader RNA–P0 binding (Fig. 1B, lanes 15–18) but less
efficiently than leader RNA. This further confirms P0–leader
RNA interaction to be a sequence-specific phenomenon.
Phosphorylated P does not interact with leader RNA
VSV and CHP P proteins have been shown to require
CKII-mediated phosphorylation at specific N-terminal sites
for their activity in transcription in vitro (Barik and Baner-
jee, 1992; Chattopadhyay et al., 1997). However, phosphor-
ylation of P protein is not essential for in vitro replication
(Pattnaik et al., 1997). As P protein is present in a variety of
phosphorylated forms in VSV-infected cells and N–leader
RNA interaction of rabies virus varies with the phosphory-
lation status of N, we looked for the effect of phosphoryla-
tion of P on its ability to interact with leader RNA. Bacte-
rially expressed P protein was phosphorylated with CKII as
described earlier (Chattopadhyay et al., 1997) until all the
P0 is converted to P1. This phosphorylated protein was used
in the RNA-binding assay. Fig. 2A shows that when phos-
phorylated by CKII, P protein can no longer bind to the
leader RNA (lane 6). A point mutant (S62A) of P protein
lacking CK II phosphorylation site when tested for its RNA-
binding ability showed similar affinity toward leader se-
quence as P0 (lane 2). The results indicate that the function
of P associated with its leader RNA-binding ability might be
separable from its role in transcription.
Considering the regulatory role of CKII-mediated phos-
phorylation of P protein on its RNA-binding ability, we
asked whether P0 bound to leader RNA can be utilized by
CKII as its substrate. To address this possibility we allowed
P0–I (both being unlabeled) complex to form, keeping re-
action components in equal molar ratio that assures most of
the protein to be present in an RNA-bound state. We have
Fig. 2. Phosphorylated P does not interact with leader RNA. (A) Three
micrograms of bacterially expressed P protein was either incubated with
CK II (Fig. 2A, lane 4) or with ATP (lane 5) or with both CKII and ATP
(lane 6) for 1 h in binding-phosphorylation buffer in 15 l reaction volume.
For lane 3, CKII and ATP were incubated together for the same period of
time omitting P protein. Three nanograms of I* (60,000 cpm) was added to
each set followed by further incubation for 15 min at 37°C. In lane 2, 3 g
of bacterially expressed Pm was incubated with I* for 15 min. Reaction
mixtures were resolved onto 6% native gel. (B) To show phosphorylation
as the key event modulating RNA-binding ability of the P protein, we have
incubated 3 g of P0 with 3 ng of I* (60,000 cpm) to allow the RNA–
protein complex to form. The complex was then further incubated for
another 15 min either alone (lane 2) or with CKII (lane 3) or with ATP
(lane 4) or with both CKII and ATP (lane 5). For lane 6, P protein
prephosphorylated by incubating with CKII and ATP for 15 min was
incubated with I* for another 15 min. Finally the reaction mixture was
resolved into 6% native gel.
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incubated this preformed complex with CKII and radiola-
beled ATP and the reaction mixture was resolved in SDS–
PAGE followed by autoradiography. Our observation sug-
gests that P0 bound to leader RNA could be phosphorylated
by CKII as efficiently as P0 alone (data not shown). To find
out the effect of phosphorylation of P0 on bound leader
RNA, we incubated labeled leader RNA–P0 complex with
CKII and ATP and resolved the reaction mixture on native
gel. We found phosphorylation by CKII not only prevents P
from binding to the leader RNA but also releases leader
RNA from the complex. When preformed P0–I complex is
phosphorylated, the protein–RNA interaction becomes
weak and the complex gradually breaks down to form a
faster migrating smear in 6% native gel (Fig. 2B, lane 5)
(Nagai and Mattaj, 1994). This observation indicates that
reversible binding of P with leader RNA can also be
achieved by CKII-mediated phosphorylation of P. However,
incubation with CKII or ATP alone (lanes 3 and 4) does not
disrupt the RNA–P0 complex, emphasizing phosphorylation
as the key event modulating RNA-binding property of P.
P0–leader RNA interaction is different from encapsidation
of RNA by N protein
A major function of rhabdoviral nucleocapsid protein is
to encapsidate viral genome into a tight nuclease-resistant
structure (Dillon and Gupta, 1988). Unlike phosphoprotein–
leader RNA interaction that is reversible in nature, we
observed N-mediated encapsidation of genome termini to be
irreversible in practical consideration. Instead of 300 ng of
P0 that has been used to test reversibility (Fig. 1B), 3 g of
N protein was used in the binding reaction to mimic viral
system where N is present in a stoichiometrically higher
amount than P. Bacterially expressed soluble N protein
when incubated with labeled leader RNA forms an encap-
sidation complex (Fig. 3A, lane 2). This leader RNA–N
protein complex, when challenged with either an increasing
gradient of cold leader RNA (Fig. 3A, lanes 3–5) or an
unlabeled nonviral RNA (lanes 6–8), did not release bound
leader probe. Although N protein of negative-stranded RNA
viruses renders the genome RNA resistant to nucleases, it
does not protect the bases from methylation (Keene et al.,
1981). To define the nature of P0–leader RNA complex, we
incubated this complex with RNase A and analyzed on 6%
non-denaturing gel. Fig. 3B demonstrates that P0 could not
protect the leader RNA from nuclease action (lane 3), but
when the same complex was treated with UV to cross-link
the protein with the bases of RNA, the complex becomes
nuclease resistant (lane 4). Under the same experimental
condition when N protein is incubated with leader RNA it
forms a nuclease-resistant complex irrespective of UV
cross-linking (Fig. 3C, lanes 3 and 4). This suggested that in
contrast to the N protein, P protein presumably interacts
with the ribonucleoside bases of the leader RNA, keeping
the phosphate backbone available for nuclease action. It
may also be due to the reversible nature of leader RNA–P0
complex whereby the released RNA is being degraded by
RNase A. Nonetheless, this temporal nuclease sensitive
interaction of P0 with leader sequence can be distinguished
from encapsidation mediated by N protein.
Fig. 3. P0–leader RNA interaction is different from encapsidation of RNA by N protein. (A) N encapsidates leader RNA in an irreversible manner. Three
micrograms of N protein was incubated with I* (60,000 cpm) and encapsidation complex thus formed was challenged with either buffer alone (lane 2) or
with equal (lanes 3 and 6), 5-fold (lane 4, 7), 10-fold (lane 5, 8) molar excess of cold leader RNA or nonviral RNA, respectively. The reaction mixture was
incubated for another 15 min before resolving onto 4% native gel. (B) For RNase protection assay 3 g of P0 was incubated with 6 ng of labeled leader RNA
(120,000 cpm) for 15 min as described allowing complex formation. The complex was then either directly loaded on gel (Fig. 4A, lane 2) or treated with
RNase A (lane 3) or UV-crosslinked and treated with RNase A (lane 4) before loading onto 6% native gel. (C) The above RNase protection experiment has
been repeated with 3 g of N protein in place of P0, keeping all the parameters constant except that the reaction mixtures were resolved into 4% native gel.
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N protein can encapsidate P0 bound leader RNA
One of the prevailing models suggests that transcription–
replication switch in Vesiculovirus is regulated by intracel-
lular concentration of N protein (Blumberg et al., 1981). It
was postulated that encapsidation of nascent RNA chain by
de novo synthesized N protein not only protects progeny
genome molecules from cellular RNases but also provides
an antitermination signal required to read through the inter-
genic sequences (Blumberg et al., 1981; Leppert and Kola-
kofsky, 1980; Patton et al., 1984). Nucleation site for this
N-mediated encapsidation process is believed to reside on
first 14 bases of leader chain (Blumberg et al., 1983),
whereas we demonstrated P0 also interacts with the posi-
tive-sense leader RNA. To verify whether P0 binding inter-
feres with the subsequent encapsidation process, we looked
at the ability of N protein to encapsidate leader RNA that is
already present in a P0 bound form. To test this idea,
preformed P0–RNA complex was incubated with an in-
creasing amount of recombinant N protein. Fig. 4A shows
while N alone can encapsidate leader RNA giving rise to a
slower migrating encapsidation complex (lanes 7–10), it is
equally efficient to enwrap leader RNA bound to P0 with a
gradual disappearance of P0–I complex upon increase in N
concentration (lanes 3–6). The efficiency of P0–leader RNA
complex encapsidation was comparable to the N-mediated
encapsidation of naked leader RNA. Preformed P0–N com-
plex was found to be equally efficient in encapsidating the
leader RNA (data not shown). UV-induced covalent cross-
linking between P0 and bound leader RNA eliminates the
temporal nature of their interaction. We observed this UV-
crosslinked P0–I complex when incubated N protein could
not be utilized for encapsidation as there was no reduction
in the intensity of the shifted band corresponding to I–P0
complex with an increase in nucleocapsid protein concen-
tration (Fig. 4B, lanes 2–5). Moreover, Western blot anal-
ysis of the encapsidation complexes formed at the expense
of leader–P0 complex (Fig. 4A, lanes 3–6) with anti-P
antibody could not demonstrate the presence of P protein
(data not shown). These results indicate that although P0 and
N protein share a common target for binding, namely leader
sequence, prior binding of P0 to leader chain does not
interfere with the subsequent encapsidation process and P
protein is displaced from the leader chain during recruit-
ment of N on RNA, exploiting the temporal nature of leader
RNA and P0 interaction in this process.
Overexpression of unphosphorylated P enhances
replication
Higher affinity of P0 to the leader RNA as compared to
that of phosphorylated protein and the ability of N protein to
encapsidate P0 bound leader RNA indicate that phosphory-
lation of P with CKII may have a regulatory role in con-
trolling transcription–replication transition. In this proposal
binding of P0 to nascent leader chain brings about the
replicative phase where the polymerase read-through gene
boundaries, eventually synthesizing a complete ()-sense
genome. These ()-sense replication intermediates act as a
Fig. 4. N protein can encapsidate leader RNA bound to P protein. (A) To show
the potentiality of RNA–P0 complex to act as substrate of N protein mediated
encapsidation 3 g of P0 was incubated with I* for 15 min allowing the
complex formation. This preformed complex was then either directly loaded
onto 4% native gel (lane 2) or incubated with 1 g (lane 3), 2 g (lane 4), 3
g (lane 5), or 4 g (lane 6) of N protein for another 15 min. For lanes 7–10
identical amounts of N protein as in lanes 3–6 were incubated with I* for 30
min. The reaction mixture was finally resolved onto 4% native gel. (B) To find
out the role of P0 bound to leader chain in recruiting N protein for encapsidation,
we incubated I* (60,000 cpm) and 3 g of P0 together, allowing complex
formation and then UV cross-linked P0–I complex. This cross-linked species
(lanes 2–5) or simply UV-treated RNA (lanes 6–9) was incubated with 1, 2,
3, or 4g of N protein for another 15 min before finally resolving onto native gel.
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template for further round of replication producing ()-
sense progeny genomes that upon packaging bud out as
mature virion particles. We wanted to test this hypothesis by
comparing the virus yield, levels of transcription, and rep-
lication in infected cells overexpressing either the wild-type
P (Pwt) or P protein lacking the CKII phosphorylation site
(Pm). The expression of Pwt and Pm proteins in the trans-
fected Vero cells was confirmed by [35S]methionine label-
ing (Fig. 5, lanes 1 and 2). To make sure that Pm is indeed
not phosphorylated, cells expressing Pm were labeled with
32P and immunoprecipitated with anti-P antibodies. Unlike
the wild-type P, there was no 32P-labeling of the mutant P
(Fig. 5, lanes 3 and 4). To find out the effect of unphos-
phorylated P protein in virus life cycle, Vero cells were
transfected with plasmid bearing Pwt or Pm gene, followed
by infection with CHP virus as described under Materials
and methods. The virus titer was measured 24 h postinfec-
tion. Transient expression of Pm enhances the viral yield by
almost 100-fold as compared to the cells expressing wild-
type P (Fig. 6).
When the relative level of viral transcription was mea-
sured by analyzing the amount of N-transcript present in the
infected cells using RT-PCR assay, it was found to be
higher in cells overexpressing wt P protein compared to the
cells overexpressing mutant P (Fig. 7, lanes 4 and 5). This
observation validates our earlier in vitro result demonstrat-
ing indispensability of CKII-mediated phosphorylation of P
protein in viral transcription (Chattopadhyay et al., 1997).
In contrast when we compared the RT-PCR products rep-
resenting both transcription and replication, we surprisingly
noticed that cells expressing Pm had more products com-
pared to that with Pwt (Fig. 7, lanes 9 and 10). As Pm does
not support viral transcription (Chattopadhyay et al., 1997),
this increase in the amount of RT-PCR products can only be
due to enhanced replication. This result suggests that the
phosphorylation-defective mutant of P boosts up viral rep-
lication, providing support to our hypothesis.
To further substantiate the observation that phosphory-
lation-defective P protein favors viral replication over tran-
scription, we did Northern analysis of the total RNA at
different time points after infection and probed for a viral-
replication product. We repeatedly found that within 4 h of
infection a considerable amount of replication products ac-
cumulate in cells expressing Pm compared to that expressing
that Pwt (Fig. 8A, lanes 2 and 3). The trend continued in the
later time points with more replication products in the Pm
population as compared to the Pwt-expressing cells (Fig. 8A,
lanes 5 and 6 and lanes 8 and 9, respectively, and Fig. 8B).
So, comparing the transcription and the transcription–repli-
cation products together, we infer that the cell population
expressing Pm supports more replication than the wt P.
Leader-sized RNA synthesis by lysed virus is decreased in
presence of Pm
To mimic our in vivo results, we carried out in vitro
transcription assay with detergent-disrupted CHP virus
(Colonno and Banerjee, 1978) in the presence of exog-
enously added Pm or P1. Lysed virus retains all the requisite
machinery to initiate RNA synthesis starting from the 3 end
of the genome and produces discrete 50-nt-long leader-
sized RNA transcript (lane 1, Fig. 9A and B). We observed
that with increasing concentrations of Pm (S62A) there was
a gradual decrease in the discrete leader-like RNA synthesis
(Fig. 9A, lanes 2–5). This inhibitory effect of Pm provides in
vitro support to the transdominant negative effect of P
protein in its unphosphorylated form on viral transcription
(Das et al., 1995; Mazumder and Barik, 1994). However, P1
showed no such effect on viral RNA synthesis in this assay
(Fig. 9A, lane 6; Fig. 9B, lane 3). Interestingly, we found
that Pm alone when used in excess (3 g/rection) can
result in synthesis of heterogeneous population of higher
molecular weight RNA of 80–200 nt (Fig. 9B, lane 2) at the
expense of discrete leader-sized RNA. These results suggest
that under the assay conditions employed, an excess amount
of Pm inhibits the synthesis of leader-sized RNA and in-
creases the synthesis of larger products which may corre-
spond to readthrough at the leader-N junction. During rep-
licative phase antitermination at the gene boundaries
eventually leads to synthesis of full-length genome mole-
cules. Thus our in vitro data were found to be in accordance
with the in vivo results showing more replication with Pm.
Fig. 5. Expression profile and phosphorylation status of wild-type and
mutant P protein in transfected VERO cells. To test the expression of Pwt
and Pm proteins and their phosphorylation status, transfected Vero cells
were metabolically labeled with [35S]methionine (lanes 1 and 2) or with
32P-inorganic phosphate (lanes 3 and 4). P protein was immunoprecipitated
from cell extract with anti-P antibody and subjected to 10% SDS–PAGE
followed by autoradiography. Protein molecular mass markers are noted at
the right in kilodaltons.
378 S. Basak et al. / Virology 307 (2003) 372–385
Discussion
The mechanism underlying the regulation of transcrip-
tion and replication of negative-stranded RNA viruses has
been elusive for many years (Ball and Wertz, 1981). This
differential regulation is believed to be due to the binding of
nascent RNA by the nucleocapsid protein which may act as
an attenuator of the mRNA processing steps during tran-
scription, thus allowing the readthrough of the intragenic
regions with concomitant synthesis and encapsidation of the
progeny genome RNA (Banerjee and Barik, 1992). Ongoing
synthesis of N protein is required not only for initiation but
also for continuation of genome replication (Banerjee,
1987). Being the major nucleocapsid protein to provide
protection to genome RNA against nuclease action as well
as the most abundant protein of the virus, it is not surprising
that replication of the virus will be dependent on its syn-
thesis. Moyer showed that in the Sendai virus system puri-
fied NP protein is necessary and sufficient for RNA synthe-
sis and encapsidation from preinitiated templates that is for
Fig. 6. Effect of Pwt or Pm protein on virus yield. To understand the effect of P protein phosphorylation on viral yield, Vero cells were transfected with either
vector alone or with recombinant clones expressing Pwt and Pm proteins. Successively, transfected cells were infected with Chandipura virus and 24 h
postinfection virus titer was measured for different sets by plaque assay.
Fig. 7. RT-PCR assay. Total RNA was isolated from cells either not transfected and not infected (control, lane 3, and lane 11) or from cells transfected with
construct expressing Pwt or Pm protein and infected with CHP Virus. RT-PCR was done in two sets as described under Materials and methods. RT-PCR
products reflecting either relative level of viral N gene-specific transcript (lane 4 and lane 5) or level of both viral N gene specific transcripts and viral genome
RNA (lanes 9 and 10) was analyzed in 1% agarose gel. Lanes 2 and 8 correspond to water control used in PCR. Used as DNA molecular weight markers
were 1 Kb DNA ladder (lanes 1 and 7) or 100 bp DNA ladder (lanes 6 and 12).
379S. Basak et al. / Virology 307 (2003) 372–385
elongation reaction but alone cannot initiate RNA replica-
tion and encapsidation. Another viral component, in addi-
tion to the NP protein, appears to be required for the initi-
ation of encapsidation, since the soluble protein fraction of
the infected but not uninfected cells did support DI-H ge-
nome replication (Baker and Moyer, 1988). A number of
biochemical studies reveal that when synthesized alone N
protein tends to form inactive aggregates and the P protein
makes it soluble as well as specific toward viral RNA
sequences (Masters and Banerjee, 1988).
In this article, we have presented a correlative study
showing that the unphosphorylated form of P protein has
specificity of binding leader RNA which could be abolished
by CKII-mediated phosphorylation. We have also demon-
strated that phosphorylation null mutant Pm favors the syn-
thesis of full-length RNA and finally proposed a modifica-
tion to the existing hypothesis explaining transcription–
replication switch.
Initial indication about the involvement of distinct forms
of P protein in replication and transcription was provided
with the isolation of a temperature-sensitive mutant having
a lesion in the P gene that cannot replicate but transcribes at
a nonpermissive temperature (Unger and Reichmann,
1973). A monoclonal antibody, raised against a form of P
protein that is not phosphorylated at some sites, is capable
of inhibiting replication but not transcription (Richardson
and Peluso, 1996). Using phosphatase inhibitor, Chuang et
al. (1997) suggested hyperphosphorylation of P prevents
replication. The possibility of P as a leader RNA-binding
protein was provided by Keene et al. (1981). P protein could
act as a cofactor necessary for the initiation of encapsida-
tion, shown in the Sendai virus system (Baker and Moyer,
1988). It was also demonstrated that the protein requirement
for initiation and elongation is different. There are several
possible explanations for the difference in the response
observed. The P protein may play a role in stabilizing and
activating the nucleocapsid protein for the initial binding to
nascent RNA.
Fig. 8. Northern blot analysis. (A) Total RNA was isolated at three different time points (4, 8, and 12 h postinfection) from cells either not transfected and
infected (control, lane 1, lane 4, and lane 7) or from cells transfected with construct expressing Pwt (lane 2, lane 5, and lane 8) or Pm (lane 3, lane 6, and
lane 9) and infected with CHP virus and probed for viral genome RNA and -actin mRNA. (B) Autoradiogram presented in (A) was scanned; band intensities
were quantitated using Matlab software version 5.1.0.421. Relative intensity of band was plotted as a percentage increase in band intensity corresponding
to viral genome RNA to that of -actin for each lane, reflecting relative level of replication in different sets. Data presented here are an average over three
independent experimental sets (one shown in A and two additional sets).
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We took the advantage of using recombinant P free from
other viral proteins and purified leader RNA synthesized by
in vitro transcription to demonstrate the binding of unphos-
phorylated P protein to leader RNA. P proteins of VSV as
well as CHP have been shown to form multimers when
phosphorylated by CKII (Chattopadhyay et al., 1997; Gao
and Lenard, 1995). Total attenuation of leader RNA-binding
ability after phosphorylation suggests that either increase in
the net negative charge prevents the interaction with acidic
leader RNA or phosphorylation-mediated conformational
alteration (Raha et al., 1999) and/or multimerization (Rich-
ardson and Peluso, 1996) may mask the RNA-binding do-
main. Recently, phosphorylation of the major phosphopro-
tein N of rabies virus has been shown to modulate its leader
RNA encapsidation (Yang et al., 1999). Cuesta et al. (2000)
reported that the structural phosphoprotein M2-1 of hRSV is
a leader RNA-binding protein and this ability is regulated
by phosphorylation as has been observed in the case of CHP
P protein in the present work.
P0–leader RNA interaction that is reversible moderately
fast in manner can also be reverted by CKII-mediated phos-
phorylation. Temporal nature of P0–leader RNA interaction
advocates a possible regulatory role in the transition point of
viral life cycle. Although N protein successfully encapsi-
dates the P0–I complex, P0 was found to be absent in the
final nucleocapsid assembly. A prerequisite of reversible
character of P0–leader RNA interaction in this encapsida-
tion process and the ability of P0–N complex to bind leader
sequence suggest that P0 bound to leader RNA may assist in
the recruitment of N on nascent chain while itself being
replaced. Interestingly, one of the established functions of P
protein is to provide specificity to the RNA-binding ability
of N protein where CKII phosphorylation of P protein was
found to be dispensable (Masters and Banerjee, 1988).
P proteins of two extensively studied serotypes of VSV
(NJ and IND) contain multiple domain I phosphorylation
sites, whereas P protein of CHP is unique in this regard,
having a single phosphorylation site in domain I. This
single-site mutated protein Pm binds to the leader RNA
similar to its unphosphorylated wild-type counterpart. To
test the relevance of the RNA-binding ability of P protein in
the viral context, we used wild-type virus instead of DI
particle to infect cells expressing Pwt or Pm Interestingly it
was found that the Pm does not facilitate transcription in
vivo, supporting our earlier in vitro observation (Chatto-
padhyay et al., 1997). It has been reported that though
phosphorylation within N terminal domain of P protein by
CKII is required for transcription, it can be compromised for
replication. P protein without CKII-mediated phosphoryla-
tion can form trimeric complexes with L and N protein,
which can support replication in vitro (Gupta and Banerjee,
1997; Pattnaik et al., 1997). In line with these reports we
found an increase in replication product with the expression
of Pm as compared to Pwt. To explain more replication with
Pm. We propose a modified model for transcription–repli-
cation switch where binding of P0 to the nascent leader
RNA initiates the replicative mode either by signaling the
polymerase complex to readthrough the gene junctions or
by promoting N-mediated encapsidation leading to antiter-
mination. A gradual decrease in the leader RNA synthesis in
the presence of Pm in virion-mediated in vitro transcription
assay along with the production of some readthrough tran-
scripts suggest that P0 bound to nascent leader chain alone
may bring about some unspecified changes in the polymer-
ase complex, resulting in a change in its function from
transcription to replication, although failure to obtain full-
length replication product in absence of N protein in this in
vitro assay underscores the requirement of a pool of de novo
synthesized N protein in viral replication. In our in vivo
experiment this requirement was satisfied by N protein
synthesized from viral genome. All these results together
suggest that P0 binding to the leader RNA sequence to be
the rate-limiting step in the transcription–replication switch,
though synthesis of full-length genome remains dependent
on continuous production and recruitment of N on nascent
chain either independently or with the help of leader-bound
P0.
In a natural situation a mutant P does not exist and one
Fig. 9. In vitro transcription assay with detergent disrupted virus. (A and B)
To test the effect of exogenously added Pm on viral transcription, we
incubated detergent-disrupted virion in transcription buffer either alone
(lane 1, A and B) or in the presence of 0.25, 0.5, 1, 1.5 (lanes 2, 3, 4, and
5, respectively, A), or 3 g of Pm (lane 2, B) as described under Materials
and methods. As an internal control 1.5 or 3 g of P1 was included in the
assay mixture (lane 6, A, and lane 3, B, respectively). Reaction mixture
was resolved on 20% polyacrylamide gel containing 7 M urea. *Transcrip-
tion products of 80–200 nt in length (B). RNA molecular mass markers
(Promega) are noted beside the autoradiograms.
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may question the existence of any unphosphorylated form
of P in the infected cell. P0 may be formed as a short-lived
intermediate (Wertz, 1983) by the action of any phosphatase
in the infected cell or a subset of newly synthesized P can
remain in unphosphorylated state in equilibrium with a
phosphorylated counterpart in the infected cell. This modi-
fied model explains some of the early observations by other
groups and is consistent with similar findings in related
viruses. Chuang et al. (1997) have proposed that switch
from transcription to replication of the genome is coupled to
assembly on nascent chains and involves a functional
change in the P–L polymerase complex. The transcription-
defective P mutants can support efficient replication of DI
RNA in vivo (Das et al., 1997). Pattnaik et al. (1997) have
proposed that replication complex and transcription com-
plexes are different and distinct in nature and CKII-medi-
ated phosphorylation of P favors the formation of transcrip-
tion complex, whereas only LAK-phosphorylated P favors
the formation of replication complex. Though Pattnaik et
al.’s model cannot explain why the polymerase composed
of L, P0, and N replicates better than it transcribes, our result
could provide an explanation for this observation. Use of
mutants disrupting different functions of P protein such as
RNA binding, oligomerization, and replication will provide
further insight about the roles of phosphorylated and un-
phosphorylated P protein in transcription and replication.
Materials and methods
Cell culture and virus
CHP virus (Strain 1653514) was purified from baby
hamster kidney (BHK-21) cells (Masters and Banerjee,
1987). All protein quantitations were made with Bio-Rad
DC protein assay reagent. Oligonucleotides used in this
study were purchased from Operon Technologies, USA.
Cloning of leader gene and 5trailer region of CHP virus
To clone 49-nt-long leader RNA gene (I) of CHP virus,
two complementary primers 3lchp1 and 3lchp2 (Table 1)
encompassing the entire leader sequence was designed.
EcoR1 or HindIII restriction site was incorporated in each
primer. PCR was done with these two primers and ampli-
fication product was restriction digested and cloned into
pGEM-4Z vector (Promega). A 46-nt-long 5-end trailer
region of the genome (t) was amplified by PCR using a pair
of overlapping primers 5tchp1 and 5tchp2 (Table 1) and
cloned similarly into pGEM-4Z vector. Sequences of both
recombinant clones were found to be identical with pub-
lished sequences of Chandipura genome (Nichol and Hol-
land, 1987).
Expression of Pwt and Pm protein in Escherichia coli
P protein or Pm (S62A) of CHP virus was overexpressed
in E. coli (BL21DE3) cells from pET-3a PC or pET-3a
PCM plasmids, respectively, as described earlier (Chatto-
padhyay et al., 1997), except that cells were induced with
500 M IPTG at 20°C for 8 h to maximize production of the
proteins in soluble form. Recombinant P protein was puri-
fied from bacterial lysate by Q-Sepharose (Pharmacia Bio-
tech) anion-exchange column (Raha et al., 1999). Fractions
containing the purified proteins were pooled together and
concentrated through Centricon (Amicon).
In vitro phosphorylation of P protein
Recombinant P protein (3 g) was phosphorylated in
vitro with 1 unit of CKII purified from rabbit reticulocyte
(Hathaway and Traugh, 1983) in binding-phosphorylation
buffer (10 mM Tris, 40 mM KCl, 150 mM NaCl, 10 mM
MgCl2, 1 mM DTT, and 100 M ATP) at 37°C for 1 h
(Chattopadhyay et al., 1997). Phosphorylated form of P
protein was used either directly in binding reaction or pu-
rified by gel filtration chromatography (Pharmacia Biotech)
from the reaction mixture. To phosphorylate P bound to
leader RNA, 3 g of P0 and 3 ng of radiolabeled leader
RNA (I*) was incubated together in binding phosphoryla-
tion buffer at 37°C for 15 min and then the complex was
further incubated with 1 unit of CKII and 100 M ATP at
37°C for 15 min. Resultant reaction mixture was directly
loaded onto 6% native polyacrylamide gel as described
below.
Expression of N gene in E. coli
N protein was expressed from pET-3a NC clones in E.
coli (BL21DE3) cells in a soluble monomer form and pu-
Table 1
Sequence of primers used in this study
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rified from bacterial lysate by anion exchange chromatog-
raphy using Mono Q column (Pharmacia Biotech) as de-
scribed (Majumder et al., 2001).
Synthesis of different RNA probes
Positive-sense leader RNA (I) and genome-sense trailer
RNA (t) was synthesized in vitro from either 3leader-Chp/
pGEM-4Z linearized with HindIII or 5trailer-Chp/
pGEM-4Z linearized with EcoR1 using SP6 RNA polymer-
ase or T7 RNA polymerase (BM), respectively, according to
the manufacturer’s protocol. Leader RNA synthesized in in
vitro transcription reaction has 12-nt vector-derived fusion
at the 5 end of the 49-nt-long leader RNA sequence,
whereas t-RNA bears a 13-nt vector-derived sequence at the
5 end of 46-nt-long viral sequence. Sixty-five-nucleotide-
long nonviral RNA used as control in this study, bearing
same 12-nt sequence at 5 termini as present in leader
transcript, was synthesized by transcribing HindIII-digested
pGEM-4Z vector with SP6 RNA polymerase. To obtain
radiolabeled RNA [32P]UTP (BRIT) was included in the
transcription reaction. In vitro synthesized RNA was eluted
from the gel, precipitated twice with ethanol, and suspended
in RNase-free water. Radioactivity was measured in liquid
scintillation counter.
Gel retardation assay (GRA)
Leader RNA probe was incubated with recombinant P
(unphosphorylated or phosphorylated in vitro with CKII),
Pm (S62A), or N protein in binding buffer (10 mM Tris, 40
mM KCl, 1 mM DTT, 10 mM MgCl2, and 100 mM NaCl)
for 15 min at 37°C in a total volume of 15 l. Native
gel-loading dye was added to the reaction mixture (final 3%
Ficoll, 0.1 mM EDTA, 0.025% Bromphenol blue, and
0.025% xylene cyanol) and finally the complex was re-
solved on a 6 or 4% native polyacrylamide gel containing
5% glycerol, run at 4°C in 1 TAE. The gel was dried and
exposed to X-ray film. To test reversibility in the supershift
experiment different amounts of unlabeled RNA as indi-
cated in figure legends or 1 g of anti-P antibody was added
to the reaction mixture at completion of RNA binding.
Samples were incubated for another 15 min before resolving
onto gel. To test the specificity-labeled pGEM-4Z-derived
nonviral control RNA was incubated in binding buffer ei-
ther alone or in the presence of P0 and loaded onto the gel.
To show N-mediated encapsidation of P0–I* complex, per-
formed complexes either directly or after UV cross-linking
were titrated with different amounts of N protein. The entire
reaction mixture was incubated for another 15 min before
resolving onto 4% native gel.
RNase protection assay
Recombinant P or N protein was incubated with I*
(120,000 cpm). The RNA–protein complex was UV cross-
linked (Majumder et al., 2001) and treated with RNAse A at
a concentration of 60 g/ml for 15 min at 37°C. Native gel
loading dye was added to the reaction mixture before load-
ing into 6 or 4% native polyacrylamide gel. Gel was dried
and exposed to X-ray film.
Expression of Pwt and Pm (S62A) protein of CHP virus in
vero cells
Full-length Pwt and Pm (S62A) genes of CHP virus were
subcloned in eukaryotic expression vector pCMXPL2 under
control of CMV promoter. Vero cells grown in minimal
essential medium supplemented with 5% fetal calf serum in
35-mm six-well plates were transfected at their 90% con-
fluency with 1 g of pCMXPL2, pCMXPL2-Pwt, or pC-
MXPL2-Pm (S62A) using lipofectamine (GIBCO-BRL).
Medium from transfected cells was removed at 24 h post-
transfection and subsequently cells were treated for immu-
nofluorescence assay accordingly using anti-CHP antibody
to follow the expression of viral proteins. The maximum
level of expression was found to occur after 12–14 h post-
transfection in all cases. For metabolic labeling 20 h post-
transfection medium was aspirated out and methionine-free
MEM or phosphate-free MEM supplemented with 35S-la-
beled methionine or 32P-labeled inorganic phosphate, re-
spectively, was added. After 4 h of incubation, cells were
collected and lysed in RIPA buffer followed by immuno-
precipitation of P protein from cell extract with anti-P an-
tibody. Immunopellet was resolved in 10% SDS–PAGE
followed by autoradiography.
Transfection-infection
As expression of foreign protein reaches a peak at 12 h
posttransfection for transfection-infection assay, we have
selected this time point for infecting transfected cells with
CHP virus. For transfection-infection experiments Vero
cells were grown and transfected as discussed earlier and
12 h posttransfection cells were infected with CHP virus at
a m.o.i. of 1. Cells were frozen and thawed 24 h postinfec-
tion to release virus particles and virus yield was measured
by plaque assay.
RT-PCR assay
Twelve hours postinfection Vero cells were washed
twice with PBS and trypsinized, and total RNA was isolated
using Tripure Reagent (GIBCO-BRL). Reverse transcrip-
tion was done simultaneously with oligo(dT)18 and N gene-
specific upstream primer in a single tube using Superscript
II (GIBCO-BRL) reverse transcriptase maintaining 0.5 g
of total cellular RNA/reaction.
For semiquantitative analysis preliminary experiments
were done to determine the optimum PCR cycle number
within the linear range of amplification for each gene being
measured. RT product was subjected to PCR reaction with
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different primer pairs corresponding to the following: (i) N
gene-specific upstream primer (Table 1) and oligo(dT)18 to
detect N gene-specific transcript and p53 (Intron 6)-specific
upstream and downstream primers (Masters and Banerjee,
1987). (ii) N gene-specific upstream and downstream prim-
ers (Table 1) (Majumder et al., 2001) to identify N mRNA
and replication product simultaneously and upstream and
downstream primers for p53 gene (Intron 6). The RT-PCR
products were electrophoresed on 1% agarose gel and visu-
alized by staining with ethidium bromide.
Northern blot analysis
Vero cells were transfected and infected with CHP virus
as described previously. Total RNA was isolated from in-
fected cells at regular time intervals postinfection and run in
1% MOPS agarose gel. RNA was Northern transferred to
Nylon membrane, UV cross-linked, and hybridized with N
gene-specific mRNA sense riboprobe generated simulta-
neously from pET3a-NC by in vitro transcription and with
-actin gene-specific probe as a control. The -actin gene-
specific probe was synthesized with the Random Priming
Kit (Boehringer Manheim) according to the manufacturer’s
protocol using [32P]dCTP (BRIT). Membrane was
washed, air-dried, and exposed to X-ray film. Autoradio-
gram was scanned and band intensities were quantitated
with Matlab version 5.1.0.421 and corrected for -actin
gene product.
In vitro transcription reconstitution
In vitro reconstitution of viral transcription was done
with detergent-disrupted CHP virus as described (Colonno
and Banerjee, 1978). Briefly, 0.1 mg/l of purified virus
was incubated in reconstitution buffer containing 0.05%
Triton N101 (50 mM Tris–HCl pH 8.0, 0.1 M NaCl, 5 mM
MgCl2, 4mM DTT) for 15 min at 37°C. This detergent-
disrupted virus was further incubated in the same buffer
supplemented with 30 M UTP, 1 mM ATP, CTP, and
GTP, 200 Ci [32P]UTP in 200 l reaction volume for 2 h
at 30°C. Indicated amounts of Pm or P1 were added to
different sets at this time point. Reaction was terminated
with 0.1% SDS, 25 g/ml yeast t-RNA (GIBCO-BRL),
followed by incubation with 200 g/ml proteinase K
(GIBCO-BRL) for 30 min at 37°C. Phenol-chloroform ex-
traction was done before ethanol precipitation. The pellet
was dissolved and loaded in 20% polyacrylamide gel con-
taining 7 M urea, run in 1 TBE. The gel was dried and
exposed to X-ray film.
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